N/A
Completed N=27
RehabTouch Home Therapy for Stroke Patients
Cerebral Stroke
Source: ClinicalTrials.gov NCT03503617 ↗
Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcomePrimary: Change in Fugl-Meyer Arm Motor Score From Baseline to One Month Post Therapy — 8.0; 3.1 Score on a Scale — p=0.03
Summary
We will investigate the efficacy of a newly developed exercise device (RehabTouch) for people in the subacute stage after a stroke compared to a traditional tabletop exercise program. RehabTouch uses embedded sensors that can track and record the patient's direction and degree of movement as they perform exercises described on a computer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Fugl-Meyer Arm Motor Score From Baseline to One Month Post Therapy |
8.0; 3.1 | 0.03 sig |
| SECONDARY Change in Box and Blocks Test Score |
31.1; 27.1 | — |
| SECONDARY 10 Meter Walk Test |
1.06; 1.07 | — |
| SECONDARY Motor Activity Log |
3.11; 2.72; 3.01; 2.50 | — |
| SECONDARY Visual Analog Pain Scale |
2.5; 4.6 | — |
| SECONDARY Modified Ashworth Spasticity Scale |
0.42; 0.63; 2.5; 2.1 | — |
Eligibility Criteria
Inclusion Criteria
- Age: 18 to 85 years old
- Upper extremity weakness measured by a clinical scale
- Absence of moderate to severe pain on affected upper extremity
- Able to understand the instructions to operate RehabTouch
Exclusion Criteria
- Concurrent severe medical problems, visual deficits, severe neglect or apraxia
- Enrollment to other therapy studies
Data sourced from ClinicalTrials.gov (NCT03503617). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.